Characteristics of Acquired β-lactamase Gene in Clinical Isolates of Multidrug-resistant Pseudomonas aeruginosa
2
조회
0
다운로드
1
인용
0
참고문헌
키워드
초록
배경: 최근 cefepime이나 carbapenem계 항균제에도 내성을 보이는 다제내성 녹농균이 증가하고 있다. 저자들은 충청지역 에서 분리된 다제내성 녹농균을 대상으로 Ambler class A, B 그리고 D 에 속하는 β-lactamase와 그들의 광범위 활성 유도 체의 빈도를 조사하고 대표적인 유전형들을 규명하고자 하였다. 방법: 2006년 3월부터 2007년 5월까지 충남대학교 병원 환자의 임상검체에서 분리된 다제내성 녹농균을 대상으로 하였 다. Metallo-β-lactamase (MBL) 생성은 inhibitor-potentiated disk diffusion 시험으로 확인하였으며 Ambler Class A, B, 그리 고 D에 해당하는 β- lactamase 유전자를 검출하기 위해 중합연쇄반응과 염기서열 분석을 하였다. 또한 돌발감염이 있었 는지를 알아보기 위해서 enterobacterial repetitive intergenic consensus (ERIC)-PCR을 수행하였다. 결과: 시험기간 중 총 37주의 다제내성 녹농균이 환자의 임상검체에서 분리되었다. 37주의 녹농균 중 29주가 blaOXA-10 (56.8%), blaOXA-2 (18.9%), 또는 blaOXA-1 (5.4%)를 가지고 있는 것으로 나타났다. IMP-1을 생성하는 균주는 단 한 주였으며 blaOXA-1도 가지고 있었다. Ambler class A β-lactamase와 class D carbapenemase는 검출되지 않았다. OXA형 β-lactamase를 가지고 있는 균주의 경우 그렇지 않은 균주 보다 aminoglycoside계 항균제에 대한 내성율이 더 높은 것으로 나타났다. ERIC-PCR 결과 OXA-10을 생성하는 19주는 유전적으로 매우 밀접한 것으로 나타났다. 결론: 충청지역의 한 대학병원에서 분리된 다제내성 녹농균에 가장 광범위하게 확산되어 있는 획득성 β-lactamase는 OXA형 β-lactamase였다. 그리고 OXA형 β-lactamase를 갖고 있는 균주들은 β-lactam계 항균제뿐 아니라 aminoglycosie 계 항균제와 qunolone계 항균제등에 대해 내성 높은 내성율을 보였다.
Abstract
Background: Recently, there have been reports of infections with multidrug-resistant Pseudomonas aeruginosa. To determine the mechanism of the resistance, we investigated the prevalence of Ambler class A and D β-lactamases, their extended-spectrum derivatives, and class B and D carbapenemase in multidrug- resistant P. aeruginosa isolates. Methods: During the period of March 2006 to May 2007, clinical isolates of multidrug-resistant P. aeruginosa were collected from patients in Chungnam National University Hospital, Daejeon, Korea. Inhibitor- potentiated disk diffusion tests were used for the screening of metallo-β-lactamase (MBL) production. PCR and DNA sequencing were conducted for the detection of β-lactamase genes. We also employed the enterobacterial repetitive intergenic consensus (ERIC)- PCR method for an epidemiologic study. Results: A total of 37 consecutive, non-duplicate, multidrug-resistant P. aeruginosa were isolated. Twentynine of 37 isolates harbored blaOXA-10 (56.8%), blaOXA-2 (18.9%), and blaOXA-1 (5.4%). Only one isolate produced IMP-1, and it also harbored blaOXA-1. None harbored Ambler class A β-lactamase or class D carbapenemase. The strains producing OXA type β-lactamases showed a significantly higher resistance to aminoglycoside compared to non-producers. The ERIC-PCR pattern of the 19 OXA-10 producing strains indicated that the isolates were closely related in terms of clonality. Conclusion: OXA type β-lactamases are the most prevalent among the acquired β-lactamases produced by multidrug-resistant P. aeruginosa isolated at a university hospital in Chungcheong Province. Besides β-lactam antibiotics, the strains harboring OXA type β-lactamase showed a significantly higher resistance to aminoglycoside and qunolone.
참고문헌 (42)
- Bergogne-Berezin E, "Pseudomonas and miscellaneous gramnegative bacilli. In: Cohen J and Powerly WG, eds. Infectious Diseases. 2nd ed", pp.2203~2217 (2003), Mosby
- Song W, "In vitro activity of β-lactams in combination with other antimicrobial agents against resistant strains of Pseudomonas aeruginosa", Int J Antimicrob Agents, 21, pp.8~12 (2003)
- Lee K, "Further increase of vancomycin-resistant Enterococcus faecium, amikacin- and fluroquinolone-resistant Klebsiella pneumoniae, and imipenem-resistant Acinetobacter spp.in Korea: 2003 KONSAR surveillance", Yonsei Med J, 47, pp.43~54 (2006)
- McGowan JE Jr, "Resistance in nonfermenting gram-negative bacteria: multidrug resistance to the maximum", Am J Infect Control, 34, pp.S29~S37 (2006)
- Weldhagen GF, "Ambler class A extended spectrum β-lactamases in Pseudomonas aeruginosa: novel developments and clinical impact", Antimicrob Agents Chemother, 47, pp.2385~2392 (2003)
- Poirel L, "Molecular and biochemical characterization of VEB-1, a novel class A extended-spectrum β-lactamase encoded by an Escherichia coli integron gene", Antimicrob Agents Chemother, 43, pp.573~581 (1999)
- Nordmann P, "Characterization of a novel extended-spectrum β-lactamase from Pseudomonas aeruginosa", Antimicrob Agents Chemother, 37, pp.962~969 (1993)
- Chen HY, "Mechanisms of resistance to β- lactam antibiotics amongst Pseudomonas aeruginosa isolates collected in the UK in 1993", J Med Microbiol, 43, pp.300~309 (1993)
- Lee S, "Prevalence of Ambler class A and D β-lactamases among clinical isolates of Pseudomonas aeruginosa in Korea", J Antimicrob Chemother, 56, pp.122~127 (2005)
- Poirel L, "GES-2, a class A β-lactamase from Pseudomonas aeruginosa with increased hydrolysis of imipenem", Antimicrob Agents Chemother, 45, pp.2598~2603 (2001)
- Watanabe M, "Transferable imipenem resistance in Pseudomonas aeruginosa", Antimicrob Agents Chemother, 35, pp.147~151 (1991)
- Riccio ML, "Characterization of the metallo-β-lactamase determinant of Acinetobacter baumannii AC-54", 97 reveals the existence of blaIMP allelic variants carried by gene cassettes of different phylogeny, 2000, pp.44, 1229~1235
- Lauretti L, "Cloning and characterization of blaVIM, a new integron-borne metallo-β-lactamase gene from a Pseudomonas aeruginosa clinical isolate", Antimicrob Agents Chemother, 43, pp.1584~1590 (1999)
- Lee K, "blaVIM-2 cassette-containing novel integrons in metallo-β-lactamase- producing Pseudomonas aeruginosa and Pseudomonas putida isolates disseminated in a Korean hospital", Antimicrob Agents Chemother, 46, pp.1053~1058 (2002)
- Toleman MA, "Molecular characterization of SPM-1, a novel metallo-β-lactamase isolated in Latin America: report from the SENTRY antimicrobial surveillance programme", J Antimicrob Chemother, 50, pp.673~679 (2002)
- Castanheira M, "Molecular characterization of a β-lactamase gene, blaGIM-1, encoding a new subclass of metallo-β-lactamase", Antimicrob Agents Chemother, 48, pp.4654~4661 (2004)
- Lee K, "Novel acquired metallo-β-lactamase gene, bla(SIM-1), in a class 1 integron from Acinetobacter baumannii clinical isolates from Korea", Antimicrob Agents Chemother, 49, pp.4485~4491 (2005)
- Donald HM, "Sequence analysis of ARI-1, a novel OXA β-lactamase, responsible for imipenem resistance in Acinetobacter baumannii 6B92", Antimicrob Agents Chemother, 44, pp.196~199 (2000)
- Bou G, "OXA-24, a novel class D β- lactamase with carbapenemase activity in an Acinetobacter baumannii clinical strain", Antimicrob Agents Chemother, 44, pp.1556~1561 (2000)
- Yoon WS, "Prevalence of imipenem-resistant Pseudomonas aeruginosa isolates and mechanisms of resistance", Korean J Clin Microbiol, 8, pp.26~33 (2005)
- Timurkaynak F, "In vitro activities of non-traditional antimicrobials alone or in combination against multidrug-resistant strains of Pseudomonas aeruginosa and Acinetobacter baumannii isolated from intensive care units", Int J Antimicrob Agents, 27, pp.224~228 (2006)
- Clinical and Laboratory Standards Institute, "Performance standards for antimicrobial susceptibility testing; sixteenth informational supplement. M100-S10(M2)", Wayne, Pensylvania; CLSI, ~ (2006)
- Oh EJ, "Prevalence of metallo-β-lactamase among Pseudomonas aeruginosa and Acinetobacter baumannii in a Korean university hospital and comparison of screening methods for detecting metallo-β-lactamse", J Microbiol Methods, 54, pp.411~418 (2003)
- Kang JH, "Prevalence of ambler class A extended-spectrum β-lactamaseproducing Escherichia coli and Klebsiella pneumoniae isolates in Korea", Korean J Clin Microbiol, 8, pp.17~25 (2005)
- Naas T, "Integron-located VEB-1 extended-spectrum β-lactamase gene in a Proteus mirabilis clinical isolate from Vietnam", J Antimicrob Chemother, 46, pp.703~711 (2000)
- Park JH, "Characterization and prevalence of Escherichia coli and Klebsiella pneumoniae isolates producing an extended spectrum β-lactamase from Korean hospitals", Korean J Lab Med, 23, pp.18~24 (2003)
- Jeon BC, "Investigation of a nosocomial outbreak of imipenem-resistant Acinetobacter baumannii producing the OXA-23-β-lactamase in Korea", J Clin Microbiol, 43, pp.2241~2245 (2005)
- Aubert D, "Oxacillinase-mediated resistance to cefepime and susceptibility to ceftazidime in Pseudomonas aeruginosa", Antimicrob Agents Chemother, 45, pp.1615~1620 (2001)
- De Champs C, "Prospective survey of β-lactamases produced by ceftazidimeresistant Pseudomonas aeruginosa isolated in a French hospital in 2000", Antimicrob Agents Chemother, 46, pp.3031~3034 (2002)
- Heritier C, "A nosocomial outbreak of Acinetobacter baumannii isolates expressing the carbapenem-hydrolysing oxacillinase OXA-58", J Antimicrob Chemother, 55, pp.115~118 (2005)
- Mendes RE, "Rapid detection and identification of metallo-β- lactamase-encoding genes by multiplex real-time PCR assay and melt curve analysis", J Clin Microbiol, 45, pp.544~547 (2007)
- Versalovic J, "Distribution of repetitive DNA sequences in eubacteria and application to fingerprinting of bacterial genomes", Nucleic Acids Res, 19, pp.6823~6831 (1991)
- Park KO, "Molecular epidemiology of infection caused by OXA-23 or IMP-1 β-lactamase-producing Acinetobacter baumannii", Korean J Lab Med, 8, pp.121~129 (2005)
- Yao JDC, "Antibacterial agents. In:Manual for Clinical Microbiology. 7th ed", pp.1474~1504 (1999), American Society for Microbiology
- Danel F, "OXA-17, a further extended-spectrum variant of OXA-10 β-lactamase, isolated from Pseudomonas aeruginosa", Antimicrob Agents Chemother, 43, pp.1362~1366 (1999)
- Aktaş Z, "PER-1- and OXA-10-like β-lactamases in ceftazidime-resistant Pseudomonas aeruginosa isolates from intensive care unit patients in Istanbul, Turkey", Clin Microbiol Infect, 11, pp.193~198 (2005)
- Poirel L, "OXA-28, an extended-spectrum variant of OXA-10 β-lactamase from Pseudomonas aeruginosa and its plasmid- and integron-located gene", Antimicrob Agents Chemother, 45, pp.447~453 (2001)
- Yan JJ, "OXA-type β-lactamases among extended-spectrum cephalosporin-resistant Pseudomonas aeruginosa isolates in a university hospital in southern Taiwan", J Microbiol Immunol Infect, 39, pp.130~134 (2006)
- Oh SJ, "Prevalence of class a extended-spectrum β-lactamases in clinical isolates of Acinetobacter baumannii and Pseudomonas aeruginosa", Korean J Lab Med, 26, pp.14~20 (2006)
- Nordmann P, "Extended-spectrum β-lactamases in Pseudomonas aeruginosa", J Antimicrob Chemother, 42, pp.128~131 (1998)
- Ito H, "Plasmid-mediated dissemination of the metallo-β-lactamase gene blaIMP among clinically isolated strains of Serratia marcescens", Antimicrob Agents Chemother, 39, pp.824~829 (1995)
- Ohara M, "Molecular characterization of imipenem-resistant Pseudomonas aeruginosa in Hiroshima, Japan", Microbiol Immunol, 51, pp.271~277 (2007)
